These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33575113)

  • 41. Investigating the potential clinical significance of long non-coding RNA 00092 in patients with breast cancer.
    Li J; Lu F; Shao X; You B
    Ann Transl Med; 2022 May; 10(10):602. PubMed ID: 35722403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microarray Analysis of the Expression Profile of Long Non-Coding RNAs Indicates lncRNA RP11-263F15.1 as a Biomarker for Diagnosis and Prognostic Prediction of Pancreatic Ductal Adenocarcinoma.
    Huang X; Ta N; Zhang Y; Gao Y; Hu R; Deng L; Zhang B; Jiang H; Zheng J
    J Cancer; 2017; 8(14):2740-2755. PubMed ID: 28928863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and Analysis of An Epigenetically Regulated Five-lncRNA Signature Associated With Outcome and Chemotherapy Response in Ovarian Cancer.
    Yang H; Gao L; Zhang M; Ning N; Wang Y; Wu D; Li X
    Front Cell Dev Biol; 2021; 9():644940. PubMed ID: 33708773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker.
    Mo X; Wu Y; Chen L; Zhai M; Gao Z; Hu K; Guo J
    J Clin Lab Anal; 2019 Feb; 33(2):e22692. PubMed ID: 30320481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance.
    Kashyap D; Sharma R; Goel N; Buttar HS; Garg VK; Pal D; Rajab K; Shaikh A
    Front Genet; 2022; 13():993687. PubMed ID: 36685962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA-mediated regulation of
    Tariq A; Hao Q; Sun Q; Singh DK; Jadaliha M; Zhang Y; Chetlangia N; Ma J; Holton SE; Bhargava R; Lal A; Prasanth SG; Prasanth KV
    RNA; 2020 Feb; 26(2):175-185. PubMed ID: 31690584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of Differentially Expressed Long Non-coding RNAs and the Associated TF-mRNA Network in Tongue Squamous Cell Carcinoma.
    Zhang M; Chen Z; Zhang S; Wu L; Jie Y; Liao Y; Huang Y; Chen J; Shi B
    Front Oncol; 2020; 10():1421. PubMed ID: 32923393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrative Analysis of Methylation and Transcriptome Identified Epigenetically Regulated lncRNAs With Prognostic Relevance for Thyroid Cancer.
    Li Q; Wang P; Sun C; Wang C; Sun Y
    Front Bioeng Biotechnol; 2019; 7():439. PubMed ID: 31998704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review: Regulation of the cancer epigenome by long non-coding RNAs.
    Forrest ME; Khalil AM
    Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long Non-coding RNA RP11-480I12.5 Promotes the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-490-3p-AURKA-Wnt/β-Catenin Axis.
    Gao X; Lai Y; Zhang Z; Ma Y; Luo Z; Li Y; Yang C; Lu G; Li J
    Front Oncol; 2020; 10():948. PubMed ID: 32733789
    [No Abstract]   [Full Text] [Related]  

  • 51. Immune Infiltration and Clinical Outcome of Super-Enhancer-Associated lncRNAs in Stomach Adenocarcinoma.
    Peng L; Peng JY; Cai DK; Qiu YT; Lan QS; Luo J; Yang B; Xie HT; Du ZP; Yuan XQ; Liu Y; Yin D
    Front Oncol; 2022; 12():780493. PubMed ID: 35311149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells.
    Vera O; Rodriguez-Antolin C; de Castro J; Karreth FA; Sellers TA; Ibanez de Caceres I
    Epigenetics; 2018; 13(3):251-263. PubMed ID: 29436261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. lncRNA Gene Signatures for Prediction of Breast Cancer Intrinsic Subtypes and Prognosis.
    Zhang S; Wang J; Ghoshal T; Wilkins D; Mo YY; Chen Y; Zhou Y
    Genes (Basel); 2018 Jan; 9(2):. PubMed ID: 29373522
    [No Abstract]   [Full Text] [Related]  

  • 54. Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics.
    Wanowska E; Samorowska K; Szcześniak MW
    Front Cell Dev Biol; 2022; 10():922351. PubMed ID: 35865634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myeloma.
    Shen Y; Feng Y; Chen H; Huang L; Wang F; Bai J; Yang Y; Wang J; Zhao W; Jia Y; Peng Y; Lei X; He A
    Life Sci; 2018 Mar; 196():133-142. PubMed ID: 29459023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.
    Sas-Chen A; Aure MR; Leibovich L; Carvalho S; Enuka Y; Körner C; Polycarpou-Schwarz M; Lavi S; Nevo N; Kuznetsov Y; Yuan J; Azuaje F; ; Ulitsky I; Diederichs S; Wiemann S; Yakhini Z; Kristensen VN; Børresen-Dale AL; Yarden Y
    EMBO Mol Med; 2016 Sep; 8(9):1052-64. PubMed ID: 27485121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines.
    Garcia-Carpizo V; Ruiz-Llorente S; Sarmentero J; González-Corpas A; Barrero MJ
    Mol Cancer Res; 2019 Mar; 17(3):720-730. PubMed ID: 30606771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
    Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
    Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk.
    Wang Y
    Cancer Biomark; 2019; 26(1):93-108. PubMed ID: 31356197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    Bradford JR; Cox A; Bernard P; Camp NJ
    PLoS One; 2016; 11(9):e0163238. PubMed ID: 27685983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.